We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Dermatology Clinicopathological Challenge |

Progressive Widespread Cutaneous Telangiectasias QUIZ

Katherine M. Hunt, BS1; Rebecca Kissel, MD2; Lucia Seminario-Vidal, MD, PhD2
[+] Author Affiliations
1University of Alabama School of Medicine, Birmingham
2Department of Dermatology, University of Alabama at Birmingham, Birmingham
JAMA Dermatol. 2014;150(10):1103-1104. doi:10.1001/jamadermatol.2014.1183.
Text Size: A A A
Published online


Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

A, Multiple telangiectasias coalescing to form large, retiform patches on the bilateral lower extremities. B, Dilated, ectatic vessels in the superficial dermis with no associated inflammation or fibrinoid necrosis (hematoxylin-eosin, original magnification ×200).

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment
Vascular Laser is the Treatment of Choice for GET
Posted on October 12, 2014
Philip Bekhor
Director Laser Unit Dept. Derm. RCH Melbourne Australia
Conflict of Interest: None Declared

A nice review of GET, however the treatment discussion lacks perspective. In reality, vascular laser works very well. My experience with 595nm Pulsed Dye Laser for this condition demonstrates very high response rates at the lower end of the fluence range. I suspect than any vascular laser or IPL operating in the 500 to 600 nm range with a large treatment spot size would be effective. In summary, vascular laser is the treatment of choice and the bizarre collection of medications that have been tried are simply an historical curiosity.

Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles